![cover image](https://wikiwandv2-19431.kxcdn.com/_next/image?url=https://upload.wikimedia.org/wikipedia/commons/thumb/f/ff/James_P._Allison_EM1B5525_%252846207775441%2529.jpg/640px-James_P._Allison_EM1B5525_%252846207775441%2529.jpg&w=640&q=50)
James P. Allison
American immunologist and Nobel laureate (born 1948) / From Wikipedia, the free encyclopedia
James Patrick Allison (born August 7, 1948)[1] is an American immunologist and Nobel laureate who holds the position of professor and chair of immunology and executive director of immunotherapy platform at the MD Anderson Cancer Center in Houston, Texas.[5] Allison is Regental Professor and Founding-Director of James P. Allison Institute at the MD Anderson Cancer Center.[6]
His discoveries have led to new cancer treatments for the deadliest cancers. He is also the director of the Cancer Research Institute (CRI) scientific advisory council. He has a longstanding interest in mechanisms of T-cell development and activation, the development of novel strategies for tumor immunotherapy, and is recognized as one of the first people to isolate the T-cell antigen receptor complex protein.[7][8]
In 2014, he was awarded the Breakthrough Prize in Life Sciences; in 2018, he shared the Nobel Prize in Physiology or Medicine with Tasuku Honjo.[9][10]